Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Dublin: 12°C Friday 19 August 2022
Advertisement

Beautiful Payday as Bono set for multi-million dollar windfall from magazine sale

The rock star’s Elevation Partners is the preferred shareholder in the magazine.

Image: Niall Carson/PA Wire/Press Association Images

U2 FRONTMAN BONO is set to make millions after Forbes Magazine was placed up for sale for the first time in its 96-year history.

Bono’s Elevation Partners private-equity firm bought a 45 per cent stake in the legacy business magazine for $264 million.

Now, the magazine has been put up for sale with a guide price of $400 million.

Most of that purchase is made up of preference shares, meaning that when the magazine is sold, Bono and his business partners stand to make millions of dollars.

They would receive the majority of the proceeds of any sale of the magazine, the third-largest business magazine in the US. It has a weekly circulation of 933,000.

No buyer has been confirmed for the business, but Forbes Media CEO Mike Perlis says that the decision to sell was based on “serious overtures”.

Making a difference

A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

For the price of one cup of coffee each week you can make sure we can keep reliable, meaningful news open to everyone regardless of their ability to pay.

“The frequency and serious nature of these overtures have brought us to a decision point,” Perlis wrote in a letter to employees.

“We have hired Deutsche Bank to represent us, and we expect interest from numerous suitors.”

Read: Paul McGuinness to step down as U2 manager

Read: 10 reasons for U2 to exist

Read next:

COMMENTS (96)